AbbVie reports Q1 2026 adjusted EPS of $2.65 on $15.0 billion in revenue and raises full-year adjusted EPS guidance to $14.08–$14.28
https://finviz.com/quote?t=ABBV&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.